Stuck in a trial and error loop?
Break free and trial blaze with our solutions!
At SIKARAM, we leverage multiomics to gain a holistic understanding of biological systems, enabling us to uncover disease mechanisms and patient responses in greater depth. Up to 80% of variations in individuals' responses to medications and side effects can be attributed to differences in 'omics' factors, which are often overlooked. By addressing these complexities, we help pharmaceutical and biotechnology companies overcome key challenges in drug development.
To translate these insights into actionable outcomes, we integrate multiomic wet lab capabilities with in-house computational analysis powered by advanced AI. This enables us to reveal complex biological patterns that drive precision medicine strategies in clinical trials.
We help you develop safer and more effective drugs while reducing development costs. Our solutions also support regulatory submissions by providing robust data on drug mechanisms and patient selection criteria, facilitating faster approvals and the development of companion diagnostics.
Our dynamic, data-driven inquiry model positions us as your trusted partner in precision medicine in clinical trials. Contact us to find out how we can customize our services to meet your specific needs.